0000904454-14-000151.txt : 20140206 0000904454-14-000151.hdr.sgml : 20140206 20140206150807 ACCESSION NUMBER: 0000904454-14-000151 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140206 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87623 FILM NUMBER: 14579707 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Domain Partners VI, L.P. CENTRAL INDEX KEY: 0001298033 IRS NUMBER: 331073839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: (609) 683-5656 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 SC 13G 1 s13g-021414_fiveprime.htm SCHEDULE 13G FOR FIVE PRIME THERAPEUTICS BY DOMAIN PARTNERS VI, L.P. s13g-021414_fiveprime.htm
 
 
 
CUSIP No. 33830X 10 4 Page 1 of 8 Pages



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
SCHEDULE 13G
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
 
Five Prime Therapeutics, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value
(Title of Class of Securities)
 
33830X 10 4
(CUSIP Number)
 
December 31, 2013
Date of Event Which Requires Filing of this Statement



Check the appropriate box to designate the rule pursuant to which this Schedule is Filed:

[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)




_______________________

1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.  The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.


 
 
 
CUSIP No. 33830X 10 4 Page 2 of 8 Pages


1)
Name of Reporting Person
I.R.S. Identification
No. of Above Person
(Entities Only)
(Voluntary)
Domain Partners VI, L.P.
2)
Check the Appropriate Box
if a Member of a Group
(a) [X]
(b) [ ]
3)
SEC Use Only
  
4)
Citizenship or Place
of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
5)
Sole Voting
Power
1,042,935 shares of Common Stock
6)
Shared Voting
Power
 
-0-
7)
Sole Dispositive
Power
1,042,935 shares of Common Stock
8)
Shared Dispositive Power
 
-0-
9)
Aggregate Amount Beneficially Owned by Each Reporting Person
1,042,935 shares of Common Stock
10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
  
11)
Percent of Class Represented by Amount in Row (9)
6.2%
12)
Type of Reporting Person
PN
 

 
 
 
CUSIP No. 33830X 10 4 Page 3 of 8 Pages


1)
Name of Reporting Person
I.R.S. Identification
No. of Above Person
(Entities Only)
(Voluntary)
DP VI Associates, L.P.
2)
Check the Appropriate Box
if a Member of a Group
(a) [X]
(b) [ ]
3)
SEC Use Only
  
4)
Citizenship or Place
of Organization
Delaware
Number of
Shares Beneficially
Owned by Each
Reporting Person
With
5)
Sole Voting
Power
10,763 shares of Common Stock
6)
Shared Voting
Power
 
-0-
7)
Sole Dispositive
Power
10,763 shares of Common Stock
8)
Shared Dispositive Power
 
-0-
9)
Aggregate Amount Beneficially Owned by Each Reporting Person
10,763 shares of Common Stock
10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
  
11)
Percent of Class Represented by Amount in Row (9)
0.1%
12)
Type of Reporting Person
PN
 


 
 
 
CUSIP No. 33830X 10 4 Page 4 of 8 Pages

Schedule 13G

Item 1(a)
–
Name of Issuer:  Five Prime Therapeutics, Inc.
     
Item 1(b)
–
Address of Issuer’s Principal Executive Offices:
     
   
2 Corporate Drive
   
South San Francisco, CA  94080
     
Item 2(a)
–
Name of Person Filing:
     
   
This statement is being filed by Domain Partners VI, L.P., a Delaware limited partnership (“Domain VI”), and DP VI Associates, L.P., a Delaware limited partnership (“DP VI A”) (together, the “Reporting Persons”).
     
Item 2(b)
–
Address of Principal Business Office:
     
   
One Palmer Square
   
Princeton, NJ  08542
     
Item 2(c)
–
Place of Organization:
     
   
Domain VI:  Delaware
   
DP VI A:  Delaware
     
Item 2(d)
–
Title of Class of Securities:
     
   
Common Stock, $0.001 par value
     
Item 2(e)
–
CUSIP Number: 33830X 10 4
     
Item 3
–
Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
     
   
Not applicable.
     
Item 4
–
Ownership.
     
 
 
 
 
CUSIP No. 33830X 10 4 Page 5 of 8 Pages
     
(a) through (c):
  
     
The information set forth in Items 5 through 9 and 11 of the cover pages to this Schedule 13G is incorporated herein by reference. Ownership is stated as of December 31, 2013 and ownership percentages are based on 16,842,134 shares of Common Stock outstanding as of December 31, 2013, as provided to the Reporting Person by the Issuer.
     
Item 5
–
Ownership of Five Percent or Less of a Class:
     
   
Not applicable.
     
Item 6
–
Ownership of More than Five Percent on Behalf of Another Person:
     
   
Not applicable.
     
Item 7
–
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Company:
     
   
Not applicable.
     
Item 8
 –
Identification and Classification of Members of the Group:
     
   
See Exhibit 2.
     
Item 9
 –
Notice of Dissolution of Group:
     
   
Not applicable.
     
Item 10
–
Certification:
     
   
Not applicable.

 
 
 
CUSIP No. 33830X 10 4 Page 6 of 8 Pages

Signature:

After reasonable inquiry and to the best of their knowledge and belief, the undersigned hereby certify that the information set forth in this statement is true, complete and correct.

Dated:  February 4, 2014

 
DOMAIN PARTNERS VI, L.P.
 
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
 
DP VI ASSOCIATES, L.P.
 
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member




 
 
 
CUSIP No. 33830X 10 4 Page 7 of 8 Pages

 EXHIBIT 2

 
JOINT FILING AGREEMENT
 
 
The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is annexed as Exhibit 2, and any amendments thereto, is and will be filed on behalf of each of them in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
 
 

 
 
Dated:  February 4, 2014
 

 
DOMAIN PARTNERS VI, L.P.
 
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
 
DP VI ASSOCIATES, L.P.
 
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member




 
 
 
CUSIP No. 33830X 10 4 Page 8 of 8 Pages

 EXHIBIT 2

    Identification and Classification of Members of the Group

Domain Partners VI, L.P. and DP VI Associates, L.P. are filing this statement on Schedule 13G as a group.

Domain Partners VI, L.P. is a Delaware limited partnership.  Its sole general partner is One Palmer Square Associates VI, L.L.C., a Delaware limited liability company.

DP VI Associates, L.P. is a Delaware limited partnership.  Its sole general partner is One Palmer Square Associates VI, L.L.C., a Delaware limited liability company.